The use and impact of trastuzumab (Herceptin) for early and late stage HER-2 positive breast cancer in Australia

Lena Caruso
This project was established to conduct a long-term evaluation of the way in which trastuzumab (Herceptin) is used to treat early and late stage breast cancer in the real world clinical setting. Secondary health data sets were linked to examine all patients receiving trastuzumab since the inception of the Herceptin Program (for late stage disease) in December 2001 and since its listing on the Pharmaceutical Benefits Scheme for early stage disease in October 2006. The...
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.